Key result
Microalbuminuria did not predict future major cardiovascular events or mortality in nondiabetic men with treated hypertension, whereas macroalbuminuria was associated with increased risk.
Why the study?
Does microalbuminuria predict future major cardiovascular events in nondiabetic men with treated hypertension?
Cohort (n=345)
Does microalbuminuria predict future major cardiovascular events in nondiabetic men with treated hypertension?
Microalbuminuria does not predict future cardiovascular morbidity or mortality in nondiabetic treated hypertensive men at high risk of coronary heart disease, whereas macroalbuminuria does.
No takes yet. Share an insight, caveat, or question.
Does not support microalbuminuria for risk stratification in nondiabetic treated hypertension; leaves open macroalbuminuria's prognostic value in prospective studies.
Stefan Agewall (1995) conducted a cohort in Treated hypertension in nondiabetic men (n=345). Microalbuminuria vs. Normoalbuminuria was evaluated on Future major cardiovascular events. Microalbuminuria did not predict future major cardiovascular events or mortality in nondiabetic men with treated hypertension, whereas macroalbuminuria was associated with increased risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: